- 201. Glutamate Receptor, Metabotropic 1
- [L-glutamate is the major excitatory neurotransmitter in the central nervous system and activates both ionotropic and metabotropic glutamate receptors. Glutamatergic neurotransmission is involved in most aspects of normal brain function and can be perturbed in many neuropathologic conditions. The metabotropic glutamate receptors are a family of G protein-coupled receptors that have been divided into 3 groups on the basis of sequence homology, putative signal transduction mechanisms, and pharmacologic properties. Group I includes GRM1 and GRM5 and these receptors have been shown to activate phospholipase C. Group II includes GRM2 and GRM3 while Group III includes GRM4, GRM6, GRM7 and GRM8. Group II and III receptors are linked to the inhibition of the cyclic AMP cascade but differ in their agonist selectivities. Alternative splice variants of the GRM1 gene have been described but their full-length nature has not been determined. (LocusLink) ( NCI )] (UMLS (NCI) C0535210) =Amino Acid, Peptide, or Protein; Receptor
| - 251. glycerol kinase
- [An enzyme that catalyzes the formation of glycerol 3-phosphate from ATP and glycerol. Dihydroxyacetone and L-glyceraldehyde can also act as acceptors; UTP and, in the case of the yeast enzyme, ITP and GTP can act as donors. It provides a way for glycerol derived from fats or glycerides to enter the glycolytic pathway. EC 2.7.1.30. ( MSH )] (UMLS (CSP) C0017868) =Amino Acid, Peptide, or Protein; Enzyme ;
=alcohol phosphotransferase;
|
- 202. Glutamate Receptor, Metabotropic 1 Gene
- [This gene plays a role in G protein-coupled receptor signal transduction and in neurotransmitter activity. ( NCI )] (UMLS (NCI) C1333711) GRM1;
GRM1 Gene =Gene or Genome | - 252. Glycerol Tricaprylate
- (UMLS (NCI) C0077030) =Lipid; Pharmacologic Substance ;
|
- 203. Glutamate Receptor, Metabotropic 5
- [The metabotropic glutamate receptors are a family of G protein-coupled neurotransmitter receptors, that have been divided into 3 groups on the basis of sequence homology, putative signal transduction mechanisms, and pharmacologic properties; activates phospholipase C and calcium-induced chloride channels (LocusLink) ( NCI )] (UMLS (NCI) C0530778) =Amino Acid, Peptide, or Protein; Receptor ;
| - 253. Glycerolipid Metabolism
- [The chemical reactions and pathways involving glycerolipids, any lipid with a glycerol backbone. Diacylglycerol and phosphatidate are key lipid intermediates of glycerolipid biosynthesis. [GOC:ai, PMID:8906569] ( GO )] (UMLS (NCI) C1158379) Glycerolipid Metabolism Pathway =Molecular Function
|
- 204. Glutamate Receptor, Metabotropic 5 Gene
- [This gene is involved in G protein-coupled receptor signal transduction and phospholipase C signal transduction. ( NCI )] (UMLS (NCI) C1333712) GRM5;
GRM5 Gene =Gene or Genome | - 254. glycerophosphate
- [first step in the phosphatidic acid synthesis pathway. ( CSP )] (UMLS (CSP) C0017881) =Carbohydrate; Biologically Active Substance ;
=phosphatide;
sugar phosphate =glycerophosphorylcholine;
CALCIUM GLYCEROPHOSPHATE;
Phosphatidic Acids;
alpha-glycerophosphoric acid |
- 205. Glutamate Receptor, Metabotropic 6
- [The metabotropic glutamate receptors are a family of G protein-coupled neurotransmitter receptors, that have been divided into 3 groups on the basis of sequence homology, putative signal transduction mechanisms, and pharmacologic properties. (LocusLink) ( NCI )] (UMLS (NCI) C0756239) GRM6;
=Amino Acid, Peptide, or Protein; Receptor | - 255. glycerophosphoric ester
- [ ] (UMLS (CSP) C1171340) =Carbohydrate; Biologically Active Substance
|
- 206. Glutamate Receptor, Metabotropic 6 Gene
- [This gene is involved in G protein-coupled receptor signal transduction and synaptic transmission. ( NCI )] (UMLS (NCI) C1333713) GRM6;
GRM6 Gene =Gene or Genome | - 256. glycerophosphorylcholine
- [component of phosphatidylcholines (lecithins), in which the two hydroxy groups of glycerol are esterified with fatty acids; it counteracts the effects of urea on enzymes and other macromolecules. ( CSP )] (UMLS (CSP) C0017889) =Lipid; Biologically Active Substance ;
=glycerophosphate;
|
- 207. glutamate transporter
- [family of potassium-dependent acidic amino acid transporters that demonstrate a high affinity for glutamate and aspartate; several variants of this system are found in neuronal tissue. ( CSP )] (UMLS (CSP) C0061467) =Amino Acid, Peptide, or Protein; Biologically Active Substance ;
=membrane transport protein;
| - 257. glyceryl ether
- [Compounds in which one or more of the three hydroxyl groups of glycerol are in ethereal linkage with a saturated or unsaturated aliphatic alcohol; one or two of the hydroxyl groups of glycerol may be esterified. These compounds have been found in various animal tissue. ( MSH )] (UMLS (CSP) C0017886) =Organic Chemical
|
- 208. GLUTAMIC ACID
- [A non-essential amino acid naturally occurring in the L-form. Glutamic acid is the most common excitatory neurotransmitter in the CENTRAL NERVOUS SYSTEM. ( MSH )] (UMLS (NCI) C0061472) =Amino Acid, Peptide, or Protein; Biologically Active Substance ;
=Amino Acids, Dicarboxylic;
[TN503] AMINO ACIDS/PROTEINS, ORAL =glutamate;
CARRINGTON DRESSING GEL SPRAY,TOP;
Glutamate 340 MG;
Glutamate 50 MG;
Glutamate 500 MG;
CARRINGTON GEL,TOP;
Glutamate 130 MG;
GLUTAMIC ACID 182 MG/GM;
GLUTAMIC ACID 2.58 MG/ML;
GLUTAMIC ACID 21 MG;
GLUTAMIC ACID 3.14 MG/ML;
GLUTAMIC ACID 3.69 MG/ML;
GLUTAMIC ACID 300 MG/100ML;
GLUTAMIC ACID 5.17 MG/ML;
GLUTAMIC ACID 5.7 MG/ML;
GLUTAMIC ACID 576 MG/100ML;
GLUTAMIC ACID 6.2 MG/ML;
GLUTAMIC ACID 6.27 MG/ML;
GLUTAMIC ACID 7.38 MG/ML;
GLUTAMIC ACID 7.49 MG/ML | - 258. glyceryl trinitrate
- [volatile vasodilator which relieves angina pectoris by stimulating guanylate cyclase and lowering cytosolic calcium; an explosive compound rendered safe when compounded in tablets with mannitol. ( CSP )] (UMLS (CSP) C0017887) =Organic Chemical; Pharmacologic Substance ;
=1,2,3-Propanetriol;
nitro compound;
coronary vasodilator;
[CV250] ANTIANGINALS =NITROGLYCERIN 0.1 MG/ML;
NITROGLYCERIN 0.15 MG;
NITROGLYCERIN 0.2 MG/ML;
NITROGLYCERIN 0.3 MG;
NITROGLYCERIN 0.4 MG;
NITROGLYCERIN 0.4 MG/ML;
NITROGLYCERIN 0.5 MG/ML;
NITROGLYCERIN 0.6 MG;
NITROGLYCERIN 0.8 MG/ML;
NITROGLYCERIN 1 MG;
NITROGLYCERIN 1.5 MG;
NITROGLYCERIN 10 MG/ML;
NITROGLYCERIN 13 MG;
NITROGLYCERIN 2 MG;
NITROGLYCERIN 2.5 MG;
NITROGLYCERIN 2.6 MG;
NITROGLYCERIN 3 MG;
NITROGLYCERIN 5 MG;
NITROGLYCERIN 5 MG/ML;
NITROGLYCERIN 6.5 MG;
NITROGLYCERIN 9 MG;
NITROGLYCERIN 0.4 MG/ACTUAT;
NITROGLYCERIN 0.2 MG;
NITROGLYCERIN 0.8 MG;
NITROGLYCERIN 2 %;
NITROGLYCERIN 0.1 MG |
- 209. Glutamic Acid Hydrochloride
- [The hydrochloride salt form of glutamic acid, a non-essential amino acid. Used as a gastric acidifier, glutamic acid hydrochloride releases hydrochloric acid into the stomach, thereby lowering gastric pH. (NCI) ( NCI )] (UMLS (NCI) C0304564) =Amino Acid, Peptide, or Protein; Pharmacologic Substance
| - 259. GLYCINE
- [non-essential amino acid; found primarily in gelatin and silk fibroin and used therapeutically as a nutrient; it is also a fast inhibitory neurotransmitter. ( CSP )] (UMLS (NCI) C0017890) =Amino Acid, Peptide, or Protein; Pharmacologic Substance; Biologically Active Substance =aa;
Neurotransmitter;
[IR100] IRRIGATION SOLUTIONS;
primary aminoacid;
[TN509] AMINO ACIDS/PROTEINS, OTHER;
=sarcosine;
(2-Mercaptopropionyl)glycine;
dihydroxyaluminum aminoacetate;
Ca-DTPA;
ANTI-THYMOCYTE GLOBULIN 50MG/ML INJ;
Calcium Carbonate 300 MG / Simethicone 40 MG Oral Tablet;
HEPATITIS B IMMUNE GLOBULIN (IM) INJ;
More… |
- 210. Glutamic Pyruvate Transaminase (Alanine Aminotransferase) 2 Gene
- [This gene plays a role in amino acid metabolism, liver gluconeogenesis and the homeostasis of fatty acid metabolism and storage. ( NCI )] (UMLS (NCI) C1425273) GPT2;
GPT2 Gene =Gene or Genome | - 260. glycine hydroxymethyltransferase
- [A pyridoxal phosphate enzyme that catalyzes the reaction of glycine and 5,10-methylene-tetrahydrofolate to form serine. It also catalyzes the reaction of glycine with acetaldehyde to form L-threonine. EC 2.1.2.1. ( MSH )] (UMLS (CSP) C0036725) =Amino Acid, Peptide, or Protein; Enzyme ;
|
- 211. Glutamic-Oxaloacetic Transaminase 1, Soluble (Aspartate Aminotransferase 1) Gene
- [This gene plays a role in amino acid metabolism, the tricarboxylic acid cycle and the urea cycle. ( NCI )] (UMLS (NCI) C1415181) GOT1;
GOT1 Gene =Gene or Genome | - 261. glycine receptor
- [glycine and GABA are the 2 major inhibitory neurotransmitters of vertebrate CNS, GABA in the brain and glycine in the spinal cord; both act through chloride channel receptors and thus membrane hyperpolarization. ( CSP )] (UMLS (CSP) C0061605) =Amino Acid, Peptide, or Protein; Receptor ;
=neurotransmitter receptor;
chloride channel |
- 212. Glutamic-Oxaloacetic Transaminase 2, Mitochondrial (Aspartate Aminotransferase 2) Gene
- [This gene is involved in the tricarboxylic acid cycle, urea cycle and amino acid metabolism. ( NCI )] (UMLS (NCI) C1415182) GOT2;
GOT2 Gene =Gene or Genome | - 262. Glycine, N-benzoyl, compound with 1,3,5,7-tetraazatricyclo(3.3.1.1(sup 3,7))decane(1:1)
- [The hippurate salt form of methenamine, a prodrug and inactive weak base that slowly hydrolyzes in acidic urine to ammonia and the effective, urinary tract antiseptic formaldehyde. Formaldehyde probably exerts its antibacterial effect by denaturation of protein. Depending on the urinary concentrations, formaldehyde is either bactericidal or bacteriostatic. Formaldehyde urinary concentrations are dependent on urine pH, volume, and flow rate. Formaldehyde acts as an antibacterial agent against gram-positive and gram-negative organisms. ( NCI )] (UMLS (NCI) C0066105) =Organic Chemical; Pharmacologic Substance =Hippurates;
METHENAMINE =METHENAMINE HIPPURATE 1 GM |
- 213. Glutamic-Pyruvate Transaminase (Alanine Aminotransferase) Gene
- [This gene is involved in amino acid metabolism and liver gluconeogenesis. ( NCI )] (UMLS (NCI) C1415274) GPT;
GPT Gene =Gene or Genome | - 263. glycinemia
- [autosomal recessive metabolic disorder caused by deficiencies in the mitochondrial glycine cleavage system; an enzyme system with four components: p-, t-, h-, and l-proteins; deficiency of the p-protein is the most prevalent form; clinical features include seizures, hypotonia, apnea, and coma; when the illness presents in childhood there tends to be an associated progressive dementia accompanied by extrapyramidal signs. ( CSP )] (UMLS (CSP) C0268559) =Disease or Syndrome =Amino Acid Metabolism, Inborn Errors;
=ketotic glycinemia;
|
- 214. Glutaminase-Asparaginase
- [A dual function enzyme derived from bacterial Acinetobacter glutaminasificans used as an adjuvant in chemotherapy. Acinetobacter glutaminase-asparaginase (AGA) possesses both L-glutaminase and L-asparaginase activities, capable of hydrolyzing glutamine and asparagine, thereby disturbing nitrogen supplies for dividing cells. When co-administered with alkylating agent melphalan, which utilizing amino acid transport systems for cellular uptake, depletion of glutamine by AGA appeared to facilitate melphalan uptake and enhance its cytotoxicity. ( NCI )] (UMLS (NCI) C0071561) =Amino Acid, Peptide, or Protein; Pharmacologic Substance; Enzyme
| - 264. GLYCLOPYRAMIDE
- (UMLS (NCI) C0607456) =Organic Chemical; Pharmacologic Substance
|
- 215. glutamine analog
- [ ] (UMLS (CSP) C0597824) =Amino Acid, Peptide, or Protein; Biologically Active Substance ;
| - 265. Glycocalyx
- [The carbohydrate-rich zone on the cell surface. This zone can be visualized by a variety of stains as well as by its affinity for lectins. Although most of the carbohydrate is attached to intrinsic plasma membrane molecules, the glycocalyx usually also contains both glycoproteins and proteoglycans that have been secreted into the extracellular space and then adsorbed onto the cell surface. (Alberts et al., Molecular Biology of the Cell, 3d ed, p502) ( MSH )] (UMLS (NCI) C0061622) =Cell Component
|
- 216. glutamyltransferase
- [ ] (UMLS (CSP) C0678107) =Amino Acid, Peptide, or Protein; Enzyme ;
=aminoacyltransferase;
=protein glutamine gamma glutamyltransferase;
| - 266. glycoconjugate
- [Carbohydrates covalently linked to a nonsugar moiety (lipids or proteins). The major glycoconjugates are glycoproteins, glycopeptides, peptidoglycans, glycolipids, and lipopolysaccharides. (From Biochemical Nomenclature and Related Documents, 2d ed; From Principles of Biochemistry, 2d ed) ( MSH )] (UMLS (CSP) C0017906) =Carbohydrate =carbohydrate;
=glycopeptide;
glycoprotein |
- 217. glutarate
- [dicarboxylic acid or its salts or esters involved in the metabolism of tryptophan and lysine. ( CSP )] (UMLS (CSP) C0017816) =Organic Chemical =dicarboxylate;
=alpha ketoglutarate;
| - 267. glycogen
- [large branched polysaccharide consisting of glucose residues; the major carbohydrate reserve of animals, stored primarily in liver and muscle, synthesized and degraded for energy as demanded. ( CSP )] (UMLS (CSP) C0017911) =Carbohydrate; Biologically Active Substance ;
=glucan;
|
- 218. glutaryl coA
- [ ] (UMLS (CSP) C0061511) =Nucleic Acid, Nucleoside, or Nucleotide; Lipid ;
| - 268. glycogen metabolism
- [The chemical reactions and pathways involving glycogen, a polydisperse, highly branched glucan composed of chains of D-glucose residues in alpha(1->4) glycosidic linkage, joined together by alpha(1->6) glycosidic linkages. [ISBN:0198506732 "Oxford Dictionary of Biochemistry and Molecular Biology"] ( GO )] (UMLS (CSP) C0599784) =Molecular Function ;
|
- 219. glutathione
- [tripeptide composed of gamma-glutamate, cysteine, and glycine; an important endogenous reducing agent involved in oxidative respiration and free radical scavenging. ( CSP )] (UMLS (CSP) C0017817) =Amino Acid, Peptide, or Protein; Biologically Active Substance ;
=oligopeptide;
Peptides;
Inactive Ingredient Preparations;
=BALANCED SALT SOLN W/BICARBONATE/DEXTROSE/GLUTATHIONE IRRG,OPH;
GLUTATHIONE 4.6 MG/ML | - 269. glycogen storage disease
- [any of a group of metabolic disorders characterized by excessive storage of glycogen. ( CSP )] (UMLS (CSP) C0017919) =Disease or Syndrome =Carbohydrate Metabolism, Inborn Errors;
enzyme deficiency =G6PD deficiency;
acid maltase deficiency;
amylo 1,6 glucosidase deficiency;
amylopectinosis;
glycogen storage disease type V;
glycogen storage disease type VI;
glycogen storage disease type VII;
glycogen storage disease type VIII;
G6PD deficiency;
acid maltase deficiency;
amylo 1,6 glucosidase deficiency;
amylopectinosis;
glycogen storage disease type V;
glycogen storage disease type VI;
glycogen storage disease type VII;
glycogen storage disease type VIII |
- 220. glutathione alkyltransferase
- [ ] (UMLS (CSP) C0598526) =Amino Acid, Peptide, or Protein; Enzyme
| - 270. glycogen storage disease type V
- [glycogenosis due to muscle phosphorylase deficiency; characterized by painful cramps following sustained exercise. ( CSP )] (UMLS (CSP) C0017924) =Disease or Syndrome =glycogen storage disease;
|
- 221. glutathione analog
- [synthetic or natural compounds which resemble glutathione in structure and/or function. ( CSP )] (UMLS (CSP) C0596621) =Amino Acid, Peptide, or Protein =peptide analog;
| - 271. glycogen storage disease type VI
- [hepatic glycogen storage disease in which there is an apparent deficiency of hepatic phosphorylase activity. ( CSP )] (UMLS (CSP) C0017925) =Disease or Syndrome =glycogen storage disease;
|
- 222. glutathione insulin oxidoreductase
- [An enzyme that catalyzes the reduction of a protein-disulfide in the presence of glutathione, forming a protein-dithiol. Insulin is one of its substrates. EC 1.8.4.2. ( MSH )] (UMLS (CSP) C0033628) =Amino Acid, Peptide, or Protein; Enzyme ;
=miscellaneous oxidoreductase;
| - 272. glycogen storage disease type VII
- [autosomal recessive glycogen storage disease in which there is deficient expression of 6-phosphofructose 1-kinase in muscle resulting in abnormal deposition of glycogen in muscle tissue; patients have severe congenital muscular dystrophy and are exercise intolerant. ( CSP )] (UMLS (CSP) C0017926) =Disease or Syndrome =glycogen storage disease;
|
- 223. Glutathione Metabolism
- [The chemical reactions and pathways involving glutathione, the tripeptide glutamylcysteinylglycine, which acts as a coenzyme for some enzymes and as an antioxidant in the protection of sulfhydryl groups in enzymes and other proteins; it has a specific role in the reduction of hydrogen peroxide (H2O2) and oxidized ascorbate, and it participates in the gamma-glutamyl cycle. [http://cancerweb.ncl.ac.uk/, ISBN:0198506732 "Oxford Dictionary of Biochemistry and Molecular Biology"] ( GO )] (UMLS (NCI) C1158188) Glutathione Metabolism Pathway =Molecular Function
| - 273. glycogen storage disease type VIII
- [x-linked recessive hepatic glycogen storage disease resulting from lack of expression of phosphorylase-b-kinase activity; symptoms are relatively mild, hepatomegaly, increased liver glycogen, and decreased leukocyte phosphorylase are present; liver shrinkage occurs in response to glucagon. ( CSP )] (UMLS (CSP) C0017927) =Disease or Syndrome =glycogen storage disease;
|
- 224. glutathione peroxidase
- [An enzyme catalyzing the oxidation of 2 moles of glutathione in the presence of hydrogen peroxide to yield oxidized glutathione and water. EC 1.11.1.9. ( MSH )] (UMLS (CSP) C0017822) =Amino Acid, Peptide, or Protein; Enzyme ;
=peroxidase;
| - 274. glycogen synthase
- [An enzyme that catalyzes the transfer of D-glucose from UDPglucose into 1,4-alpha-D-glucosyl chains. EC 2.4.1.11. ( MSH )] (UMLS (CSP) C0017932) =Amino Acid, Peptide, or Protein; Enzyme ;
=hexosyltransferase;
|
- 225. Glutathione Peroxidase 1 Gene
- [This gene plays a role in the inhibition of oxidative stress and increases cellular resistance to toxic challenges. ( NCI )] (UMLS (NCI) C1415275) GPX1;
GPX1 Gene =Gene or Genome | - 275. Glycogen Synthase Kinase 3 Alpha Gene
- [This gene is involved in carbohydrate metabolism, signal transduction and the regulation of apoptosis. ( NCI )] (UMLS (NCI) C1415320) GSK3A;
GSK3A Gene =Gene or Genome |
- 226. glutathione reductase
- [Catalyzes the oxidation of GLUTATHIONE to GLUTATHIONE DISULFIDE in the presence of NADP+. Deficiency in the enzyme is associated with HEMOLYTIC ANEMIA. Formerly listed as EC 1.6.4.2. ( MSH )] (UMLS (CSP) C0017824) =Amino Acid, Peptide, or Protein; Enzyme ;
=NAD(P)H oxidoreductase;
| - 276. Glycogen-Rich Carcinoma
- [A carcinoma characterized by the presence of malignant epithelial cells with abundant clear cytoplasm which contains glycogen. A representative example is the glycogen-rich, clear cell breast carcinoma. ( NCI )] (UMLS (NCI) C0334319) =Neoplastic Process
|
- 227. Glutathione S-Transferase M1
- [Glutathione S-transferases (GSTs) are a family of phase II enzymes which comprise at least four classes, a, m, p and q. The GSTM1 gene is one of the m-class forms and is classified into three genotypes, GSTM1A, GSTM1B, and GSTM1 (0/0). The GSTM1 (0/0) genotype due to inherited homozygous deletion of both alleles has no enzymatic activity. The GSTM1 (0/0) genotype has been possibly implicated in elevated risks of lung and urothelial cancer. (Japanese Journal of Clinical Oncology,Pages 657-660). ( NCI )] (UMLS (NCI) C0764347) Glutathione S-Transferase Mu-1;
GST Class-Mu-1;
GSTM1;
GSTM1 Protein;
GSTM1-1;
GSTM1-2;
GTH4;
HB Subunit 4 =Amino Acid, Peptide, or Protein; Enzyme ;
| - 277. glycogenesis
- [formation of glycogen in organisms or living cells. ( CSP )] (UMLS (CSP) C0596623) =Molecular Function =carbohydrate biosynthesis;
glucose metabolism |
- 228. Glutathione S-Transferase M1 Gene
- [This gene plays a role in the phase II metabolism of both endogenous compounds and xenobiotics. ( NCI )] (UMLS (NCI) C0919534) GSTM1;
GSTM1 Gene;
=Gene or Genome ;
| - 278. glycogenolysis
- [biosynthesis of glucose by hydrolysis of glycogen. ( CSP )] (UMLS (CSP) C0596624) =Molecular Function =glucose metabolism;
|
- 229. Glutathione S-Transferase Pi Gene
- [This gene is involved in phase II metabolism of both endogenous compounds and xenobiotics. ( NCI )] (UMLS (NCI) C0919451) GSTP1;
GSTP1 Gene;
=Gene or Genome ;
| - 279. Glycol, polyethylene
- [an addition polymer of ethylene oxide and water. ( CSP )] (UMLS (NCI) C0032483) =Organic Chemical; Pharmacologic Substance; Biomedical or Dental Material =Ethylene Glycols;
polyethylene;
Polymer;
[GA202] HYPEROSMOTIC LAXATIVES;
[PH000] PHARMACEUTICAL AIDS / REAGENTS;
Unclassified Ingredients;
Inactive Ingredient Preparations;
=Polyethylene Glycol 1000;
POLYETHYLENE GLYCOL 6000;
Polyethylene Glycol 8000;
POLYETHYLENE GLYCOL 300;
PEG-400;
POLYETHYLENE GLYCOL 4000;
POLYSORBATE;
Nonoxynol;
Octoxynol;
polidocanol;
(Monomethoxypolyethylene Glycol Succinimidyl)74-L-Asparaginase;
CHOLETH-24;
tyloxapol;
Poloxamer;
OLETH-3 More… |
- 230. Glutathione S-Transferase Theta 1
- [Glutathione S-transferase theta 1 is a member of a superfamily of proteins that catalyze the conjugation of reduced glutathione to a variety of electrophilic and hydrophobic compounds. The theta class includes GSTT1 and GSTT2. In humans, the GSTT1 enzyme is found in the erythrocyte and this may act as a detoxification sink. (LocusLink and OMIM) ( NCI )] (UMLS (NCI) C0971015) Glutathione-S-Transferase T1;
GSTT1 =Amino Acid, Peptide, or Protein; Enzyme ;
| - 280. glycolate
- [hydroxyacetic acid or its salts or esters; an intermediate in the conversion of serine to glycine. ( CSP )] (UMLS (CSP) C0017948) =Organic Chemical =Fatty Acids, Volatile;
Hydroxy Acids =phenoxyacetate;
GLYCOLIC ACID;
|
- 231. Glutathione S-Transferase Theta 1 Gene
- [This gene plays a role in phase II metabolism of both endogenous compounds and xenobiotics. ( NCI )] (UMLS (NCI) C1333715) GSTT1;
GSTT1 Gene =Gene or Genome | - 281. glycolic aciduria
- [ ] (UMLS (CSP) C0268164) =Disease or Syndrome ;
|
- 232. Gluteal
- (UMLS (HL7) C1550262) =Body Part, Organ, or Organ Component =Body Part;
| - 282. glycolipid
- [compound containing one or more monosaccharide residues bound by a glycosidic linkage to a hydrophobic moiety such as an acylglycerol, a sphingoid, a ceramide, or a prenyl phosphate. ( CSP )] (UMLS (CSP) C0017950) =Lipid; Biologically Active Substance ;
=lipid;
=asialoganglioside;
galactolipid;
|
- 233. Gluteal Artery
- (UMLS (NCI) C0226371) =Body Part, Organ, or Organ Component
| - 283. glycolipopeptide
- [ ] (UMLS (CSP) C0598532) =Amino Acid, Peptide, or Protein ;
|
- 234. glutelin
- [A protein substance of wheat which is intermixed with the starchy endosperm of the grain. It causes the carbon dioxide produced during dough fermentation to be retained by the dough in a manner which provides the porous and spongy structure of bread. (From Merck Index, 11th ed) ( MSH )] (UMLS (CSP) C0017842) =Amino Acid, Peptide, or Protein; Biologically Active Substance ;
| - 284. glycolysis
- [called the Embden-Meyerhoff or glycolytic pathway in which glucose is anaerobically catabolized into the simpler compounds lactic acid or pyruvic acid, resulting in energy stored in the form of ATP. ( CSP )] (UMLS (NCI) C0017952) =Molecular Function =glucose metabolism;
=fermentation |
- 235. gluten free
- [Gluten free diet for celiac disease. ( HL7V3.0 )] (UMLS (HL7) C1550573) =Intellectual Product =Diet;
| - 285. glycopeptide
- [peptides with covalently attached carbohydrate, usually resulting from biodegradation or laboratory hydrolysis of glycoproteins. ( CSP )] (UMLS (CSP) C0017953) =Amino Acid, Peptide, or Protein =glycoconjugate;
Peptides =BLEO;
peptidoglycan;
BLEO;
VANCOMYCIN;
|
- 236. GLUTETHIMIDE
- [A hypnotic and sedative. Its use has been largely superseded by other drugs. ( MSH )] (UMLS (NCI) C0017845) =Organic Chemical; Pharmacologic Substance ;
=Piperidones;
[CN309] SEDATIVES/HYPNOTICS, OTHER =2-(p-Aminophenyl)-2-ethylglutarimide;
| - 286. Glycopeptide Antibiotic
- [One of a class of antibiotics originally isolated from plant and soil bacteria with structures containing either a glycosylated cyclic or polycyclic nonribosomal peptide. These antibiotics inhibit the cell wall structure of susceptible organisms (principally Gram-positive cocci) by inhibiting peptidoglycan synthesis. First-generation glycopeptide antibiotics include vancomycin, teicoplanin, and ramoplanin; second-generation semi-synthetic glycopeptide antibiotics include oritavancin, dalbavancin, and telavancin. ( NCI )] (UMLS (NCI) C0162724) =Amino Acid, Peptide, or Protein; Antibiotic ;
|
- 237. Gluteus
- (UMLS (HL7) C1744702) =Body Part, Organ, or Organ Component ;
=Body Part;
| - 287. glycophorin
- [family of acidic integral membrane glycoproteins whose sialate groups impart a net negative charge to erythrocytes. ( CSP )] (UMLS (CSP) C0017954) =Amino Acid, Peptide, or Protein; Biologically Active Substance ;
=glycoprotein;
membrane protein |
- 238. Gluteus Maximus
- (UMLS (NCI) C0224424) =Body Part, Organ, or Organ Component
| - 288. Glycophorin A (Includes MN Blood Group) Gene
- [This gene plays a role in erythrocyte regulation. ( NCI )] (UMLS (NCI) C1367455) GYPA;
GYPA Gene =Gene or Genome |
- 239. Gluteus Medius
- (UMLS (NCI) C0224425) =Body Part, Organ, or Organ Component =Body Part;
| - 289. glycoprotein
- [ubiquitous family of proteins with covalently attached oligosaccharide side chains which impart unique properties of solubility, size, antigenicity, ligand affinity, cellular targetting, and stability. ( CSP )] (UMLS (NCI) C0017968) =Amino Acid, Peptide, or Protein; Carbohydrate ;
=glycoconjugate;
gene product =Adhesion Molecule;
glycophorin;
intrinsic factor;
alpha 1 acid glycoprotein;
osteonectin;
proteoglycan;
TG;
bone sialoprotein;
apolipoprotein J;
Entactin;
Fibrillin;
MAG (myelin associated glycoprotein);
zona pellucida glycoprotein;
amyloid protein;
colony stimulating factor;
mucoprotein;
TG |
- 240. Glutoxim
- (UMLS (NCI) C1138321) =Amino Acid, Peptide, or Protein; Pharmacologic Substance
| - 290. glycoprotein 100
- [gp 100. A tumor-specific antigen used in the development of cancer vaccines. ( NCI )] (UMLS (NCI) C0281722) =Amino Acid, Peptide, or Protein; Pharmacologic Substance; Immunologic Factor
|
- 241. GLV
- [causes many kinds of leukemia in newborn mice and rats. ( CSP )] (UMLS (NCI) C0018252) =Virus ;
=MLV;
| - 291. Glycoprotein A33 (Transmembrane) Gene
- [This gene plays a role in transcription and is a member of the immunoglobulin superfamily. ( NCI )] (UMLS (NCI) C1364020) GPA33;
GPA33 Gene =Gene or Genome |
- 242. glycan
- [linear or branched chain structure containing many sugar molecules linked by glycosidic bonds. ( CSP )] (UMLS (CSP) C0032594) =Carbohydrate; Pharmacologic Substance ;
=carbohydrate;
=gag(glycosaminoglycan);
Pentosan;
bacterial polysaccharide;
hexosan;
Alginates;
carrageenan;
Fructans;
galactan;
glucan;
gag(glycosaminoglycan);
GUM;
KARAYA;
mannan;
oligosaccharide;
Pectins;
Pentosan;
bacterial polysaccharide;
Tragacanth;
maltodextrin | - 292. glycoprotein biosynthesis
- [anabolic formation of glycoproteins in organisms or living cells. ( CSP )] (UMLS (CSP) C0596625) =Molecular Function =protein biosynthesis;
|
- 243. glycation
- [nonenzymically catalyzed glycosylation reaction important in diabetes mellitus, where hemoglobin, crystallin, and other proteins may be damaged by glycation; advanced glycosylation end-products (AGEs) are glycation-crosslinked protein complexes. ( CSP )] (UMLS (CSP) C0598528) =Phenomenon or Process ;
=Glycosylation;
| - 293. Glycoprotein Degradation
- [The chemical reactions and pathways resulting in the breakdown of glycoproteins, any protein that contains covalently bound glycose (i.e. monosaccharide) residues other than as a moiety of nucleic acid; the glycose occurs most commonly as oligosaccharide or fairly small polysaccharide but occasionally as monosaccharide. [GOC:go_curators, ISBN:0198506732 "Oxford Dictionary of Biochemistry and Molecular Biology"] ( GO )] (UMLS (NCI) C1157969) Glycoprotein Degradation Pathway =Molecular Function
|
- 244. glyceraldehyde
- [aldose, the aldehyde form of the triose derived by oxidation of glycerol. ( CSP )] (UMLS (CSP) C0017854) =Carbohydrate =triose;
| - 294. glycoprotein G
- [ ] (UMLS (CSP) C0599537) =Amino Acid, Peptide, or Protein; Biologically Active Substance
|
- 245. glyceraldehyde 3 phosphate dehydrogenase
- [Enzymes that catalyze the dehydrogenation of GLYCERALDEHYDE 3-PHOSPHATE. Several types of glyceraldehyde-3-phosphate-dehydrogenase exist including phosphorylating and non-phosphorylating varieties and ones that transfer hydrogen to NADP and ones that transfer hydrogen to NAD. ( MSH )] (UMLS (CSP) C0017857) =Amino Acid, Peptide, or Protein; Enzyme ;
=aldehyde/ketone oxidoreductase;
| - 295. glycoprotein IIb IIIa receptor
- [Platelet membrane glycoprotein complex important for platelet adhesion and aggregation. It is an integrin complex containing INTEGRIN ALPHAIIB and INTEGRIN BETA3 which recognizes the arginine-glycine-aspartic acid (RGD) sequence present on several adhesive proteins. As such, it is a receptor for FIBRINOGEN; VON WILLEBRAND FACTOR; FIBRONECTIN; VITRONECTIN; and THROMBOSPONDINS. A deficiency of GPIIb-IIIa results in GLANZMANN THROMBASTHENIA. ( MSH )] (UMLS (CSP) C0016011) =Amino Acid, Peptide, or Protein; Immunologic Factor; Receptor
|
- 246. glyceraldehyde phosphate
- [An aldotriose which is an important intermediate in glycolysis and in tryptophan biosynthesis. ( MSH )] (UMLS (CSP) C0017855) =Carbohydrate; Biologically Active Substance ;
| - 296. glycoprotein structure
- [ ] (UMLS (CSP) C0596626) =Amino Acid, Peptide, or Protein =protein structure;
|
- 247. glyceric acid phosphate
- [intermediates in the glycolysis pathway of glucose metabolism. ( CSP )] (UMLS (CSP) C0597219) =Carbohydrate ;
=sugar phosphate;
=diphosphoglycerate | - 297. Glycoproteins
- [Protein-bound polysaccharide from the mushroom Coriolus versicolor (Shitake); a biological response modifier with antitumor activity. ( NCI )] (UMLS (NCI) C0072522) =Carbohydrate; Pharmacologic Substance ;
|
- 248. glyceride
- [glycerol esterified with one or more organic acids, particularly long chain fatty acids. ( CSP )] (UMLS (CSP) C0017860) =Carbohydrate; Lipid; Pharmacologic Substance =lipid;
=triglyceride;
1,2-diacylglycerol;
Diglycerides;
triglyceride;
glyceryl monostearate;
Monoctanoin;
ACETYLATED MONOGLYCERIDE;
SOYBEAN OIL/LECITHIN/GLYCERIDES | - 298. GLYCOPYRROLATE
- [A synthetic quaternary ammonium anticholinergic agent with antimuscarinic activity. Glycopyrrolate binds to peripheral muscarinic receptors and inhibits cholinergic transmission present in the autonomic effector cells of smooth muscle, cardiac muscle, the sinoatrial node, the atrioventricular node, exocrine glands, and in the autonomic ganglia. As a result, the volume and free acidity of gastric secretions and excessive pharyngeal, tracheal, and bronchial secretions are reduced. ( NCI )] (UMLS (NCI) C0017970) =Organic Chemical; Pharmacologic Substance ;
=ammonium compound;
parasympatholytic agent;
Pyrrolidines;
=GLYCOPYRROLATE 0.2 MG/ML;
GLYCOPYRROLATE 1 MG;
GLYCOPYRROLATE 2 MG |
- 249. glycerol 3 phosphate dehydrogenase
- [ ] (UMLS (CSP) C0017875) =Amino Acid, Peptide, or Protein; Enzyme ;
=alcohol oxidoreductase;
iron sulfur protein | - 299. glycosidase
- [covering the sugar hydrolases. ( CSP )] (UMLS (CSP) C0017976) =Amino Acid, Peptide, or Protein; Enzyme ;
=hydrolase;
=N glycosidase;
O glycosidase;
amylase;
Cellulase;
Galactosidases;
Glucosidases;
chondroitinase |
- 250. glycerol dehydrogenase
- [ ] (UMLS (CSP) C0061557) =Amino Acid, Peptide, or Protein; Enzyme ;
| - 300. Glycoside
- [any compound that contains a constituent sugar, in which the hydroxyl group attached to the first carbon is substituted by an alcoholic, phenolic, or other group. ( CSP )] (UMLS (NCI) C0017977) =Carbohydrate =carbohydrate;
=Aminoglycoside Agents;
macrolide antibiotic;
cardiac glycoside;
digitonin;
galactoside;
Aureolic acid;
NOVOBIOCIN;
VANCOMYCIN;
riboside;
terpene saponin;
glucuronide;
[AM300] AMINOGLYCOSIDES;
macrolide antibiotic;
Bioflavonoid;
cardiac glycoside;
Glucosides;
LINCOMYCIN;
NOVOBIOCIN;
nucleoside;
nucleotide;
TANNIC ACID |
home
